0001104659-22-099236.txt : 20220912
0001104659-22-099236.hdr.sgml : 20220912
20220912160200
ACCESSION NUMBER: 0001104659-22-099236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220908
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Isett Thomas Francis 3rd
CENTRAL INDEX KEY: 0001773100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35023
FILM NUMBER: 221238595
MAIL ADDRESS:
STREET 1: C/O IBIO INC. 600 MADISON AVENUE
STREET 2: SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iBio, Inc.
CENTRAL INDEX KEY: 0001420720
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262797813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
BUSINESS PHONE: 302 355-0650
MAIL ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
FORMER COMPANY:
FORMER CONFORMED NAME: iBioPharma, Inc.
DATE OF NAME CHANGE: 20080806
FORMER COMPANY:
FORMER CONFORMED NAME: InB:Biotechnologies, Inc.
DATE OF NAME CHANGE: 20071210
4
1
tm2225675d1_4.xml
FORM 4
X0306
4
2022-09-08
0
0001420720
iBio, Inc.
IBIO
0001773100
Isett Thomas Francis 3rd
C/O IBIO, INC.
8800 HSC PARKWAY
BRYAN
TX
77807
1
1
0
0
CEO and Executive Chairman
Stock Option (right to buy)
0.274
2022-09-08
4
A
0
2000000
0
A
2032-09-07
Common Stock
2000000
2000000
D
These options vest ratably in equal monthly instalments over a 36-month period beginning on the date of the grant (September 8, 2022), subject to the conditions of the iBio, Inc. 2020 Omnibus Incentive Compensation Plan, as amended, and the related stock option grant agreement.
/s/Thomas F. Isett
2022-09-12